|This Slide: #14 of 100|
Slide #14. Bayer AG — Merck Consumer Care Business
Merck Consumer Care Business (NYSE:MRK)
Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced that it has entered into a definitive agreement to sell its Merck Consumer Care (MCC) business to Bayer AG (BAYRY) for $14.2 billion. Under the terms of the agreement, Bayer AG will acquire Merck's existing OTC business, including the global trademark and prescription rights for Claritin and Afrin.
Buy (3.00 out of 4)